✨
AI Summary
- Tough biotech funding environment discussed.
- Aurigene Oncology highlights CAR-T therapy and reimbursement models.
- Focus on bispecifics and multispecifics in oncology.
Guests on This Episode
AG
Anju Ghangurde
1 podcast appearance
MR
Murali Ramachandra
1 podcast appearance